T cell dependence on mTOR signaling

被引:19
作者
Mills, Robyn E. [2 ]
Jameson, Julie M. [1 ]
机构
[1] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA
[2] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
关键词
T cell; signaling; skin; cell trafficking; cell proliferation; LYMPHOCYTE TRAFFICKING; MAMMALIAN TARGET; WOUND REPAIR; RAPAMYCIN; RICTOR; ACTIVATION; COMPLEX; PHOSPHORYLATION; CYTOSKELETON; AKT/PKB;
D O I
10.4161/cc.8.4.7625
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The mammalian target of rapamycin (mTOR) signaling pathway integrates signals from the environment to the nucleus for the regulation of cellular growth, metabolism and survival. Lymphocytes frequently rely on this pathway, but it is carefully regulated through the reception of signals via cytokine, growth factor and co-stimulatory receptors. Recent studies have begun to elucidate why T cell subsets rely on this pathway to varying degrees. Ultimately these findings will help distinguish the parameters that guide T cell homeostasis and activation-induced function between the different T cell populations. The mTOR pathway has been the focus of many immunosuppressive and cancer treatment regimens, therefore there is a great need to understand the impact of suppression not only on the T cell populations targeted, but on bystander T cells as well.
引用
收藏
页码:545 / 548
页数:4
相关论文
共 29 条
  • [1] LIMITED DIVERSITY OF GAMMA-DELTA-ANTIGEN RECEPTOR GENES OF THY-1+ DENDRITIC EPIDERMAL-CELLS
    ASARNOW, DM
    KUZIEL, WA
    BONYHADI, M
    TIGELAAR, RE
    TUCKER, PW
    ALLISON, JP
    [J]. CELL, 1988, 55 (05) : 837 - 847
  • [2] Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin
    Basu, Samik
    Golovina, Tatiana
    Mikheeva, Tatiana
    June, Carl H.
    Riley, James L.
    [J]. JOURNAL OF IMMUNOLOGY, 2008, 180 (09) : 5794 - 5798
  • [3] Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
    Battaglia, M
    Stabilini, A
    Roncarolo, MG
    [J]. BLOOD, 2005, 105 (12) : 4743 - 4748
  • [4] Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients
    Battaglia, Manuela
    Stabilini, Angela
    Migliavacca, Barbara
    Horejs-Hoeck, Jutta
    Kaupper, Thomas
    Roncarolo, Maria-Grazia
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 177 (12) : 8338 - 8347
  • [5] Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells
    Coenen, JJA
    Koenen, HJPM
    van Rijssen, E
    Hilbrands, LB
    Joosten, I
    [J]. BLOOD, 2006, 107 (03) : 1018 - 1023
  • [6] The Pim kinases control rapamycin-resistant T cell survival and activation
    Fox, CJ
    Hammerman, PS
    Thompson, CB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (02) : 259 - 266
  • [7] Regulation of cutaneous malignancy by γδ T cells
    Girardi, M
    Oppenheim, DE
    Steele, CR
    Lewis, JM
    Glusac, E
    Filler, R
    Hobby, P
    Sutton, B
    Tigelaar, RE
    Hayday, AC
    [J]. SCIENCE, 2001, 294 (5542) : 605 - 609
  • [8] RECOGNITION OF SELF ANTIGENS BY SKIN-DERIVED T-CELLS WITH INVARIANT GAMMA-DELTA-ANTIGEN RECEPTORS
    HAVRAN, WL
    CHIEN, YH
    ALLISON, JP
    [J]. SCIENCE, 1991, 252 (5011) : 1430 - 1432
  • [9] The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells
    Haxhinasto, Sokol
    Mathis, Diane
    Benoist, Christophe
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (03) : 565 - 574
  • [10] Upstream and downstream of mTOR
    Hay, N
    Sonenberg, N
    [J]. GENES & DEVELOPMENT, 2004, 18 (16) : 1926 - 1945